Shares of Bridgepoint Group plc (LON:BPT – Get Free Report) rose 0.4% during trading on Thursday . The stock traded as high as GBX 279.40 and last traded at GBX 274.80. Approximately 59,879,270 shares changed hands during trading, an increase of 597% from the average daily volume of 8,592,735 shares. The stock had previously closed at GBX 273.60.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. upped their price target on shares of Bridgepoint Group from GBX 395 to GBX 415 and gave the company a “buy” rating in a research report on Monday, January 5th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Bridgepoint Group presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 385.
Check Out Our Latest Research Report on BPT
Bridgepoint Group Stock Performance
Insider Activity
In related news, insider Ruth Prior purchased 179,000 shares of the firm’s stock in a transaction that occurred on Friday, November 14th. The stock was bought at an average cost of GBX 278 per share, with a total value of £497,620. Also, insider Cyrus Taraporevala acquired 100,000 shares of the stock in a transaction on Friday, November 14th. The stock was bought at an average price of GBX 284 per share, with a total value of £284,000. Company insiders own 0.64% of the company’s stock.
Bridgepoint Group Company Profile
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Featured Stories
- Five stocks we like better than Bridgepoint Group
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.
